Eli Lilly and Company announced a 38% increase in Q2 revenue to $15.56 billion, with net income up by 91%. The company also highlighted advancements in its oncology and cardiometab...
Sun Pharma, India's largest drugmaker, is set to acquire Checkpoint Therapeutics for $355 million, enhancing its oncology portfolio with FDA-approved UNLOXCYT for advanced skin can...
Sun Pharma, India's leading drugmaker, is set to acquire Checkpoint Therapeutics for over Rs 3000 crore, including the FDA-approved UNLOXCYT for advanced skin cancer. This move enh...
Reliance Industries, led by Mukesh Ambani, has acquired Karkinos Healthcare for Rs 375 crore, marking a significant expansion into the oncology sector. Karkinos specializes in earl...
